Article

Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancer

2020-01-01

Abstract excerpt

Liquid biopsies, using analytes such as circulating tumour DNA (ctDNA), can detect and quantify cancer in a minimally invasive way and can provide information on tumour heterogeneity. Current limitations in the liquid biopsy field are centred around the general sensitivity of the present assays and the input and logistical requirements for sensitive detection. While detection rates from liquid biopsy platforms are...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a6b9cb00-a712-5737-a017-7363b6be9782
DOI: 10.17863/cam.50695

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancerDOI 10.17863/cam.50695Read

ctDNA detection by personalised assays in early-stage NSCLCSemantic proximity Read

Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challengesSemantic proximity Read

Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment.Semantic proximity Read

Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNASemantic proximity Read

ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung CancerSemantic proximity Read

An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.Semantic proximity Read

Clinical Utility of ctDNA Analysis in Lung Cancer—A ReviewSemantic proximity Read

Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection.Semantic proximity Read

Circulating DNA addresses cancer monitoring in non small cell lung cancer patients for detection and capturing the dynamic changes of the diseaseSemantic proximity Read

Liquid biopsy tracking of lung tumor evolutions over timeSemantic proximity Read

Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients.Semantic proximity Read

Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer.Semantic proximity Read